This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Astex Therapeutics Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Rajdeep Kaur Benning
Introduction
Rajdeep Kaur Benning is a notable inventor based in Uxbridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target receptor tyrosine kinases. His work is crucial in the ongoing fight against diseases such as cancer.
Latest Patents
Rajdeep Kaur Benning holds a patent for "Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases." This invention relates to new bicyclic heterocyclic derivative compounds, which are essential for creating pharmaceutical compositions. These compounds are designed for use in treating various diseases, including cancer.
Career Highlights
Rajdeep has established himself as a key figure in the pharmaceutical industry. His innovative approach to drug development has garnered attention and respect from his peers. He is currently associated with Astex Therapeutics Limited, where he continues to advance his research and development efforts.
Collaborations
Throughout his career, Rajdeep has collaborated with talented individuals such as Valerio Berdini and Maria Grazia Carr. These partnerships have enhanced his research and contributed to the success of his projects.
Conclusion
Rajdeep Kaur Benning's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions are paving the way for new treatments that could significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile